Yeol-Hong Kim

President at YUHAN CORPORATION

Net worth: 377 847 $ as of 30/06/2026

67 year

Health Technology

Commercial Services

Profile

Yeol-Hong Kim is Co-President, Executive Director, and Head of R&D at Yuhan Corp.
since 2024.
Dr. Kim is Non-Executive Director at ProGen Co., Ltd. since 2024.
Dr. Kim is Non-Executive Director at Immuneoncia Therapeutics, Inc. since 2023.
Dr. Kim was Non-Executive Director at Aprilbio Co. Ltd. in 2024.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
YUHAN CORPORATION 0.01%	09/06/2026	8,339 ( 0.01% )	377 847 $	30/06/2026

Yeol-Hong Kim active positions

Companies	Position	Start
YUHAN CORPORATION	President	15/03/2024
PROGEN CO., LTD.	Director/Board Member	28/03/2024
IMMUNEONCIA THERAPEUTICS, INC.	Director/Board Member	26/12/2023

All active positions of Yeol-Hong Kim

Former positions of Yeol-Hong Kim

Companies	Position	End
APRILBIO CO.,LTD.	Director/Board Member	31/10/2024

See the detail of Yeol-Hong Kim's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yeol-Hong Kim's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Yuhan Corp. Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products	Health Technology
Aprilbio Co. Ltd. Aprilbio Co. Ltd. BiotechnologyHealth Technology Operates as a drug development bio company	Health Technology
Immuneoncia Therapeutics, Inc. Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients	Health Technology
Progen Co., Ltd. Progen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical sciences and pharmacy products	Commercial Services